{"id":780971,"date":"2023-06-29T11:02:19","date_gmt":"2023-06-29T08:02:19","guid":{"rendered":""},"modified":"2025-02-06T12:51:13","modified_gmt":"2025-02-06T10:51:13","slug":"ukrayina-gotova-do-vidrodzhennya-galuzi-klinichnyh-doslidzhen","status":"publish","type":"post","link":"https:\/\/new.eba.com.ua\/en\/ukrayina-gotova-do-vidrodzhennya-galuzi-klinichnyh-doslidzhen\/","title":{"rendered":"Ukraine is ready to revive the clinical trials industry!"},"content":{"rendered":"

The clinical trials industry faced the unprecedented challenges of the rf\u2019 full-scale war against Ukraine and martial law. In the first months of a full-scale war, all those involved in clinical trials – investigators and clinical sites, sponsors, CRO, logistics and service companies, companies involved in the transportation of patients, laboratories, as well as state regulatory bodies, ethics commissions – in close cooperation were able to rebuild their work in extremely difficult conditions and do everything possible to continue to ensure patient safety, stability and reliability of data, support and preserve their teams.<\/span><\/p>\n

Read the Open Letter<\/a><\/p>\n

The clinical trials industry in Ukraine has gained unique experience in supporting, restoring and ensuring the proper conduct of clinical trials during extremely difficult circumstances – it has endured, adapted, stabilized and started to recover with the potential to scale in the near future. We can already say that there are real opportunities and conditions for the stable involvement of new international clinical trials to be successfully conducted in the conditions of a new reality!<\/span><\/p>\n

According to the assessment of the current state of the clinical trials by the experts of the Clinical Trials Subcommittee of the European Business Association, the existing signs of recovery and the level of adaptation to current conditions fully contribute to further active recovery and the attraction of a greater number of new clinical trials already now.<\/span><\/p>\n

During one and a half years of full-scale war, work in active clinical trials did not stop, measures were taken to improve the conditions of clinical trials (introduction of electronic submission, shortening of CT material expertise terms to 30 days, regulation of continued treatment of patients with the investigational product after finishing of their participation in clinical trial, etc.). All clinical trials stakeholders have demonstrated a high level of reliability in their work to ensure patient safety and data reliability in extreme conditions, as well as proven the ability to effectively collaborate between the regulator, business and clinical sites and quickly adapt to the new reality. Clinical trial sites have confirmed their <\/span>readiness, <\/span>willingness and ability to participate in new clinical trials. Active work is ongoing to further improve the regulatory environment for the development of clinical trials in Ukraine.<\/span><\/p>\n

At present, the most favorable conditions have been created for the rapid recovery of clinical trials in Ukraine.<\/span><\/p>\n

Ukraine is ready to contribute to the development of innovative medicines in the world.<\/span><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The clinical trials industry faced the unprecedented challenges of the rf\u2019 full-scale war against Ukraine and martial law. In the first months of a full-scale war, all those involved in clinical trials – investigators and clinical sites, sponsors, CRO, logistics and service companies, companies involved in the transportation of patients, laboratories, as well as state […]<\/p>\n","protected":false},"author":4489,"featured_media":487736,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[15564,15563],"tags":[],"class_list":["post-780971","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lobbying-news-en","category-main-news-en"],"_links":{"self":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/780971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/users\/4489"}],"replies":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/comments?post=780971"}],"version-history":[{"count":0,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/780971\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media\/487736"}],"wp:attachment":[{"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/media?parent=780971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/categories?post=780971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.eba.com.ua\/en\/wp-json\/wp\/v2\/tags?post=780971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}